Gene: LRSAM1
Official Full Name: leucine rich repeat and sterile alpha motif containing 1provided by HGNC
Gene Summary: This gene encodes a ring finger protein involved in a variety of functions, including regulation of signaling pathways and cell adhesion, mediation of self-ubiquitylation, and involvement in cargo sorting during receptor endocytosis. Mutations in this gene have been associated with Charcot-Marie-Tooth disease. Multiple transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jan 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO05351 | LRSAM1 Knockout cell line (HeLa) | Human | LRSAM1 | 1:3~1:6 | Negative | Online Inquiry |
KO05352 | LRSAM1 Knockout cell line (HCT 116) | Human | LRSAM1 | 1:2~1:4 | Negative | Online Inquiry |
KO05353 | LRSAM1 Knockout cell line (HEK293) | Human | LRSAM1 | 1:3~1:6 | Negative | Online Inquiry |
KO05354 | LRSAM1 Knockout cell line (A549) | Human | LRSAM1 | 1:3~1:4 | Negative | Online Inquiry |
LRSAM1 gene knockout cell lines are genetically modified cellular models in which the LRSAM1 (ligase RING finger 1 and SAM domain containing 1) gene has been selectively disrupted. This product serves as a pivotal tool in elucidating the gene's role in cellular processes such as immune response, autophagy, and protein turnover. By employing CRISPR-Cas9 or other advanced gene-editing techniques, these knockout cell lines enable researchers to investigate the phenotypic consequences of LRSAM1 ablation, providing insights into its function in health and disease.
The mechanisms by which LRSAM1 influences cellular pathways are complex. As an E3 ubiquitin ligase, LRSAM1 is integral to the ubiquitin-proteasome system, regulating protein degradation and signaling that are vital for maintaining cellular homeostasis. Disruption of LRSAM1 can lead to dysregulation of these pathways, showcasing the potential of these cell lines in studying pathological conditions such as cancer, neurodegeneration, and autoimmune disorders.
In research and clinical settings, LRSAM1 gene knockout cell lines are invaluable for investigating the molecular underpinnings of disease states linked to this gene. They provide a robust platform for drug discovery, functional assays, and therapeutic intervention studies, paving the way for the development of targeted therapies.
Compared to traditional experimental models, the specific advantages of LRSAM1 knockout cell lines lie in their precision and reproducibility. They offer an accurate representation of the gene's loss-of-function effects, facilitating more reliable data collection than models that are not gene-edited.
For researchers and clinicians, these cell lines represent a vital investment in advancing the understanding of LRSAM1-related mechanisms and their implications in various diseases. They embody a significant breakthrough in genetic manipulation, ultimately leading to better therapeutic strategies.
Our company specializes in providing high-quality genetic tools and models to support the life sciences community. With a commitment to innovation and scientific excellence, we ensure that our products, including the LRSAM1 gene knockout cell lines, equip researchers with the resources they need to achieve their scientific goals efficiently and effectively.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.